Invesco’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,157
| Closed | -$159K | – | 3941 |
|
|
2024
Q1 | $159K | Buy |
8,157
+6,339
| +349% | +$124K | ﹤0.01% | 3674 |
|
|
2023
Q4 | $37.6K | Sell |
1,818
-783
| -30% | -$16.2K | ﹤0.01% | 3762 |
|
|
2023
Q3 | $82.7K | Sell |
2,601
-40
| -2% | -$1.27K | ﹤0.01% | 3732 |
|
|
2023
Q2 | $88.7K | Buy |
2,641
+1,971
| +294% | +$66.2K | ﹤0.01% | 3734 |
|
|
2023
Q1 | $27.9K | Sell |
670
-23
| -3% | -$959 | ﹤0.01% | 3775 |
|
|
2022
Q4 | $23.5K | Buy |
+693
| New | +$23.5K | ﹤0.01% | 3941 |
|
|
2022
Q2 | – | Sell |
-999
| Closed | -$37K | – | 4089 |
|
|
2022
Q1 | $37K | Buy |
999
+59
| +6% | +$2.19K | ﹤0.01% | 3915 |
|
|
2021
Q4 | $92K | Sell |
940
-172
| -15% | -$16.8K | ﹤0.01% | 3878 |
|
|
2021
Q3 | $139K | Buy |
1,112
+141
| +15% | +$17.6K | ﹤0.01% | 3847 |
|
|
2021
Q2 | $122K | Buy |
971
+84
| +9% | +$10.6K | ﹤0.01% | 3841 |
|
|
2021
Q1 | $120K | Buy |
887
+63
| +8% | +$8.52K | ﹤0.01% | 3721 |
|
|
2020
Q4 | $75K | Buy |
+824
| New | +$75K | ﹤0.01% | 3648 |
|